SINOPHARM (01099) intends to appoint Sun Jinglin as an executive director.
China National Pharmaceutical Group Corporation (01099) announced in a statement that on January 8, 2025, the board of directors has resolved to recommend the appointment of Mr. Sun Jinglin...
Sinopharm (01099) announced that on January 8, 2025, the board of directors proposed to appoint Mr. Sun Jinglin (Mr. Sun) as an executive director, and to appoint Mr. Hu Ligang (Mr. Hu), Mr. Zu Jing (Mr. Zu), and Mr. Xing Yonggang (Mr. Xing) as non-executive directors.
Due to work requirements, Mr. Wang Kan and Mr. Wang Peng resigned as non-executive directors on January 8, 2025, and their resignations took effect immediately.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


